Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.

Davignon, J

Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects. [electronic resource] - The American journal of cardiology Apr 1998 - 17F-24F p. digital

Publication Type: Journal Article; Review

0002-9149

10.1016/s0002-9149(98)00253-7 doi


Animals
Clofibrate--pharmacology
Drug Evaluation--methods
Drug Evaluation, Preclinical
Drugs, Investigational--pharmacology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Hyperlipidemias--drug therapy
Hypolipidemic Agents--pharmacology
Legislation, Drug
Probucol--pharmacology